At a glance
ClinicalIndex Comparison RecordN/ACompleted· 305 enrolled
Drug / intervention
Cinacalcetdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
In Brief
An observational study evaluating Cinacalcet for Hyperparathyroidism, Primary. Completed, enrolled 305 participants.
Detailed Summary
This is a multicentre, descriptive observational study of adult patients with primary HPT receiving cinacalcet in clinical practice in a number of countries in Europe. Patients will be enrolled within 1 month of initiating cinacalcet treatment, and data will be collected prospectively for up to 1 year from initiation. Data will continue to be collected from patients discontinuing cinacalcet before the end of this period.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHyperparathyroidism, Primary
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2009
Enrollment StartOct 2009
Primary CompletionDec 2011
Study CompletionFeb 2012
TodayJul 2026
First PostedJun 26, 2009
Enrollment StartOct 1, 2009
Primary CompletionDec 1, 2011
Study CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 17.0 years ago
Interventions
Cinacalcetdrug